Add Yahoo as a preferred source to see more of our stories on Google. The research that the FDA considered was spearheaded by the Multidisciplinary Association for Psychedelic Studies (MAPS), which ...

A novel, non-hallucinogenic, experimental drug shows statistically significant, rapid, and durable improvement in PTSD symptom severity in a phase 2 trial.

New research reveals that psilocybin and MDMA promote long-term PTSD recovery by physically remodeling myelin insulation in ...

FDA staff raised concerns about the available safety data and limitations in the study design for midomafetamine (MDMA) to treat post-traumatic stress disorder (PTSD) in briefing documents released ...

Efforts to make MDMA legally available as a psychotherapeutic catalyst hit a daunting roadblock on Tuesday when an expert panel overwhelmingly voted to recommend that the Food and Drug Administration ...

Add Yahoo as a preferred source to see more of our stories on Google. This photo provided by the Center for Psychedelic Therapy Research shows a Yehuda Lab MDMA-assisted therapy treatment room at the ...

Only two drugs are formally approved for post-traumatic stress disorder, or PTSD, and they don’t help everyone. A lack of effective treatment options has led some patients to seek out the psychedelic ...

Mind Medicine (MindMed) Inc. (MNMD) is a biotech that should be on everyone's watch list. The reason why I state this is that it has been able to make substantial improvements in the MDMA treatment ...

The Food and Drug Administration’s (FDA) recent rejection of midomafetamine (MDMA), along with mental health therapy, for the treatment of post-traumatic stress disorder (PTSD) came as no surprise.

A panel of advisers to the U.S. health regulator on Tuesday voted against a therapy based on the party drug MDMA for patients with post-traumatic stress disorder, in a major setback to the nascent ...

Repeat use of MDMA (3,4-methylenedioxymethamphetamine), otherwise known as ecstasy, may increase self-reported "emotional empathy" over time, new research suggests. In a cross-sectional study of the ...

When the Food and Drug Administration (FDA) declined to approve MDMA-assisted psychotherapy as a treatment for post-traumatic stress disorder (PTSD) last year, the details of its objections were not ...